DANIEL GEFFKEN

Profile

First Name

: DANIEL

Middle Name

:

Last Name

: GEFFKEN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
SYNLOGIC, INC.
PETER BARRETT, AOIFE BRENNAN, LEWIS GEFFEN, JOSE CARLOS GUTIERREZ-RAMOS, CHAU KHUONG, NICK LESCHLY, ANKIT MAHADEVIA, ED MATHERS, PAUL MILLER, TODD SHEGOG
EXECUTIVE OFFICER
LYSOSOMAL THERAPEUTICS, INC.
CORNELIS BEEN, BRUCE BOOTH, BRUCE L. BOOTH, ROBERT CARPENTER, BERNARD DAVITIAN, STEVEN HALL, STEVEN E. HALL, DIMITRI KRAINC, CAROLE NEUCHTERLEIN, CAROLE NUECHTERLEIN, HENRI TERMEER, CLAY THORP, PETER WIRTH
EXECUTIVE OFFICER
OPSONIX, INC.
ERIC J DEVROE, ERIC J. DEVROE, LEWIS GEFFEN, BRIAN PEREIRA, BRIAN J. G. PEREIRA, PRIYANKA ROHATGI, ANNE SISSEL, ANDREW STEVENSON
EXECUTIVE OFFICER
APELLIS PHARMACEUTICALS, INC.
ROBERT ADELMAN, STEVEN AXON, MARIE-CLAUDE BERNAL, GERALD CHAN, BIHUA CHEN, DAVID DARST, DAVID DARST, JR., PASCAL DESCHATELETS, A. SINCLAIR DUNLOP, SINCLAIR DUNLOP, CEDRIC FRANCOIS, STEPHEN GILLIES, FEDERICO GROSSI, MAHA KATABI, ROBERT KIM, ALEC MACHIELS, STEPHANIE O-BRIEN, DOUGLAS ONSI, NICOLE PERRY, DAVID WATSON
DIRECTOR
ARCTURUS THERAPEUTICS LTD.
PAD CHIVUKULA, STUART COLLINSON, JOSEPH E PAYNE, DAVID SHAPIRO, ORLI TORI, CRAIG WILLETT
EXECUTIVE OFFICER, DIRECTOR
VEDANTRA PHARMACEUTICALS, INC.
JULIAN ADAMS, CAROL ASHE, DANIEL BEHR, ISAAC BLECH, BEN BRONSTEIN, YEKATERINA CHUDNOVSKY, ROBERT CONNELLY, STEVE DEITCHER, OFER GONEN, FRANK HALUSKA, CHRISTOPHER HAQQ, SATISH JINDAL, DAPHNE KARYDAS, ISAAC KOHLBERG, WILLIAM KOSTER, ANNETTE MATTHIES, ROBERT RUFFOLO, ASSAF SEGAL, ALAN SHAW
DIRECTOR
SG DAN HOLDINGS LLC
GREGG BELOFF, HANNAH CRAVEN, LAURENS GOFF, JIN KIM
EXECUTIVE OFFICER, DIRECTOR
ELICIO THERAPEUTICS, INC.
JULIAN ADAMS, CAROL ASHE, DANIEL BEHR, ISAAC BLECH, BEN BRONSTEIN, YEKATERINA CHUDNOVSKY, ROBERT CONNELLY, STEVE DEITCHER, OFER GONEN, FRANK HALUSKA, CHRISTOPHER HAQQ, SATISH JINDAL, DAPHNE KARYDAS, ISAAC KOHLBERG, WILLIAM KOSTER, ANNETTE MATTHIES, ROBERT RUFFOLO, ASSAF SEGAL, ALAN SHAW
DIRECTOR
WINDTREE THERAPEUTICS INC /DE/
RUSSELL CLAYTON, D.O., KATHRYN COLE, JOHN C. COOPER, JOHN G. COOPER, GEORGE COX, CRAIG FRASER, CRAIG E. FRASER, THOMAS C. HOY, JAMES HUANG, JOHN LEONE, JOHN R. LEONE, MICHAEL L. MAGEE, JOSEPH MAHADY, JOSEPH M. MAHADY, THOMAS F. MILLER, PH.D., MBA, BRUCE PEACOCK, BRUCE A. PEACOCK, MARVIN E. ROSENTHALE, MARVIN E. ROSENTHALE, PH.D., BRIAN SCHREIBER, STEVEN SIMONSON, STEVEN A. SIMONSON, JOHN TATTORY, JOHN A. TATTORY, MARY B. TEMPLETON, MARY B. TEMPLETON, ESQ., LAWRENCE A. WEINSTEIN
EXECUTIVE OFFICER
PROMIS NEUROSCIENCES INC.
GEORGE ADAMS, LARRY ALTSTIEL, HANS BLACK, NEIL CASHMAN, MERYL CHERTOFF, JANET CLENNETT, WILLIAM COPELAND, PHILLIPE COUILLARD, GAIL M. FARFEL, DANIEL E. GEFFKEN, ANTHONY GIOVINAZZO, ELLIOT GOLDSTEIN, RICHARD GREGORY, ROBERT GUNDEL, JOHANNE KAPLAN, PATRICK KIRWIN, PATRICK D. KIRWIN, JAMES KUPIEC, WILLIAM A. LAMBERT, GAVIN T. MALENFANT, JOSH MANDEL-BREHM, AZIZ MEKOUAR, JAMES PARSONS, STEVEN PLOTKIN, JOHANNES ROTH, JOHANNES MINHO ROTH, MAGGIE SHAFMASTER, MICHAEL SONNENREICH, GRAHAM STRACHAN, WALTER VON WARTBURG, NEIL K. WARMA, WARREN WHITEHEAD, EUGENE WILLIAMS, WILLIAM WYMAN
EXECUTIVE OFFICER
CALCIMEDICA SUBSIDIARY, INC.
LAKMIR CHAWLA, MICHAEL DIEM, MICHAEL DUNN, MICHAEL J. DUNN, BRIAN GALLAGHER, KENT GOSSETT, VIKAS GOYAL, EVELYN GRAHAM, SUDARSHAN HEBBAR, A. RACHEL LEHENY, JOHN MCDONALD, ROBERT G. MCNEIL, PETER MCWILLIAMS, PETER C.M. MCWILLIAMS, FRED MIDDLETON, ERIC ROBERTS, ERIC W. ROBERTS, KEN STAUDERMAN, KENNETH A. STAUDERMAN, GONUL VELICELEBI, ROBERT WILSON, TIMOTHY WOLLAEGER, GORDON WONG
EXECUTIVE OFFICER
CALCIMEDICA, INC.
ERIC BJERKHOLT, GERALD CAGLE, GERALD CAGLE, PH.D., JEFFREY CLELAND, JEFFREY L. CLELAND, EMMETT CUNNINGHAM, EMMETT CUNNINGHAM, M.D., PH.D., MICHAEL J. DUNN, FREDERIC GUERARD, JUSTIN HANES, SUDARSHAN HEBBAR, HANSOO MICHAEL KEYOUNG, CHAU KHOUNG, CHAU KHUONG, A. RACHEL LEHENY, FRED MIDDLETON, MICHAEL O-ROURKE, ERIC W. ROBERTS, CHRISTY SHAFFER, CHRISTY SHAFFER, PH.D., ALLAN SHAW, KENNETH A. STAUDERMAN, PAMELA WAPNICK, CAMERON WHEELER, CAMERON WHEELER, PH.D., ROBERT N. WILSON, CHRISTY WYSKIEL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-04-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-20 
2023-04-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-20 
2022-11-02
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-12 
2022-10-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2022-10-11 
2022-05-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-12 
2021-11-18
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
2021-11-12
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
2021-10-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
2021-09-09
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2021-08-25 
2020-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
2020-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-27 
2019-12-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-12-06 
2019-11-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-25 
2019-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-30 
2018-10-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-28 
2018-09-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-30 
2018-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-20 
2018-06-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-21 
2018-02-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-27 
2018-01-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-11-15 
2017-11-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-27 
2017-08-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-07 
2017-01-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2016-02-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2016-01-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2015-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-23 
2015-02-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2014-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-07